It is quite remarkable that 20% of the severe COVID-19 patients sequenced from this clinical trial [8] possessed DOCK8 mutations (Table 1), and 10% (4/39) of MIS-C children who underwent DNA sequencing had DOCK8 mutations [22]. The gene discussed is DOCK8; the disease is COVID-19.